ClinVar Miner

Submissions for variant NM_001458.5(FLNC):c.8129G>A (p.Trp2710Ter)

dbSNP: rs1585173340
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Kowloon West Cluster Laboratory Genetic Service, Princess Margaret Hospital RCV000855733 SCV000998852 pathogenic Myofibrillar myopathy 2019-11-12 criteria provided, single submitter clinical testing The variant has been observed to segregate in symptomatic individuals in seven Hong Kong Chinese families with probable founder effect. The variant is absent in gnomAD. The variant is predicted to cause a premature stop codon p.Trp2710* in the last exon. Another neighboring variant c.8130G>A is also a known pathogenic variant.
Invitae RCV001038999 SCV001202505 pathogenic Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant 2023-10-08 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Trp2710*) in the FLNC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 16 amino acid(s) of the FLNC protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with filaminopathy (PMID: 15929027, 22961544). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 694402). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects FLNC function (PMID: 22961544, 26472074, 26969713). For these reasons, this variant has been classified as Pathogenic.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV001267920 SCV001446430 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV001267920 SCV002023740 pathogenic not provided 2020-02-19 criteria provided, single submitter clinical testing
OMIM RCV001290001 SCV001478055 pathogenic Myofibrillar myopathy 5 2021-01-22 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.